Close Menu

Kevin Clarke, whose portrait of James Watson is this month’s Blunt End, lives in New York City and is developing a book and exhibitions exploring the role of genetics in the aftermath of the 9/11 attack on the World Trade Center. Clarke’s work is currently on view in “How Human? Life in the Post-Genome Era” at the International Center of Photography, New York, through June 8, and in “Four Plus: Writing DNA” at the Wellcome Trust, London, until July.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.